BIAVA Mariangela | Department of Chemistry and Pharmaceutical Technology, University "La Sapienza"
スポンサーリンク
概要
関連著者
-
CAPPELLI Andrea
Department of Pure and Applied Medicinal Chemistry, University of Siena
-
FIORAVANTI Antonella
Department of Clinical Medicine and Immunology, Rheumatology Unit
-
TINTI Laura
Department of Clinical Medicine and Immunology, Rheumatology Unit
-
PASCARELLI Nicola
Department of Clinical Medicine and Immunology, Rheumatology Unit
-
LAMBOGLIA Antonello
Department of Clinical Medicine and Immunology, Rheumatology Unit
-
BIAVA Mariangela
Department of Chemistry and Pharmaceutical Technology, University "La Sapienza"
-
GIORDANI Antonio
Rottapharm Madaus
-
NICCOLINI Silvia
Department of Clinical Medicine and Immunology, Rheumatology Unit
-
GALEAZZI Mauro
Department of Clinical Medicine and Immunology, Rheumatology Unit
-
ANZINI Maurizio
Department of Pure and Applied Medicinal Chemistry, University of Siena
-
DI CAPUA
Department of Pure and Applied Medicinal Chemistry, University of Siena
-
Cappelli Andrea
Department of Pure and Applied Medicinal Chemistry, University of Siena, Italy
-
Capua Angela
Department of Pure and Applied Medicinal Chemistry, University of Siena, Italy
-
Tinti Laura
Department of Clinical Medicine and Immunology, Rheumatology Unit, University of Siena, Italy
-
Anzini Maurizio
Department of Pure and Applied Medicinal Chemistry, University of Siena, Italy
-
BIAVA Mariangela
Department of Chemistry and Pharmaceutical Technology, University "La Sapienza"
-
Niccolini Silvia
Department of Clinical Medicine and Immunology, Rheumatology Unit, University of Siena, Italy
-
Pascarelli Nicola
Department of Clinical Medicine and Immunology, Rheumatology Unit, University of Siena, Italy
-
Lamboglia Antonello
Department of Clinical Medicine and Immunology, Rheumatology Unit, University of Siena, Italy
-
Galeazzi Mauro
Department of Clinical Medicine and Immunology, Rheumatology Unit, University of Siena, Italy
著作論文
- In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β
- In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β